Pathos

Where the Future of Drug Development Begins

Chicago, United States · Founded 2020 · $467.0M raised

Headquarters
Chicago, Illinois
Employees
51–200
Founded
2020
Business Model
B2B
Website
pathos.com
Total Funding
$467.0M
Last Round
$365.0M Series DMay 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Pathos is an AI-enabled clinical-stage biotech re-engineering drug development for precision oncology. Using the largest multimodal oncology dataset and thousands of AI agents, we simulate trials, identify responsive patient subgroups, and accelerate therapies from hypothesis to clinic. Our platform de-risks development, improves success rates, and delivers better outcomes faster.

Summary

Pathos is an Artificial Intelligence company based in Chicago, United States, founded in 2020. It has raised $467.0M in total across 4 rounds, most recently a $365.0M Series D round in May 2025. Investors include Revolution Growth, Sofinnova Partners and Earlybird Venture Capital.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DMay 2025
$365.0M

Sign up to see all 4 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pathos on Indexed.vc
<a href="https://indexed.vc/companies/pathos"><img src="https://indexed.vc/api/badge/company/pathos" alt="Pathos on Indexed.vc" width="260" height="76" /></a>